Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Suspicious

<< Previous

Bullboard Posts

Next >>

Post by BioTeckon May 06, 2022 11:52am

334 Views

Post# 34662365

Suspicious

So the price is clearly being held at the 1.40 range. Given the conditions of the market and Sernova's history, we should have been back to the Canaccord PP price by now. The fact we haven't makes me suspicious. Usually this means an upcoming PP but i don't think the management is even dumb enough to do that now. Then again, no one expected the Canaccord "deal" either.

<< Previous

Bullboard Posts

Next >>

Nintendo stock jumps despite Q2 financials, new console news